Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Study Director
Takeda
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
89 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Royal Adelaide Hospital
Adelaide, South Australia, Australia
Withdrawn - St Vincents Hospital Melbourne - Ppds
Fitzroy, Victoria, Australia
Matthew ConronRecruiting
- Lkh-Universitätsklinikum Graz
Graz, Austria
Martin WagnerRecruiting - Medizinische Universität Innsbruck
Innsbruck, Austria
Heinz ZollerRecruiting - Klinikum Klagenfurt Am Wörthersee
Klagenfurt, Austria
Markus Peck-RadosavljevicRecruiting - Medizinische Universität Wien (medical University of Vienna)
Vienna, Austria
Mattias MandorferRecruiting
- Uz Antwerpen
Antwerp, Belgium
Sven FrancqueRecruiting - Uz Leuven
Leuven, Belgium
Jef VerbeekRecruiting
- Hospital de Base Do Distrito Federal
Brasília, Brazil
Liliana Mendes Sampaio CostaRecruiting - Hospital Sirio-Libanes
São Paulo, Brazil
Gilda PortaRecruiting - Universidade Estadual Paulista Julio de Mesquita Filho Faculdade de Medicina Campus de Botucatu
São Paulo, Brazil
Fernando Romeiro GomesRecruiting
- Gi Research Institute
Vancouver, British Columbia, Canada
Hin Hin KoRecruiting - Queen Elizabeth Ii Health Sciences Center
Halifax, Nova Scotia, Canada
Julie ZhuRecruiting - Inspiration Research Limited
Toronto, Ontario, Canada
Kenneth ChapmanRecruiting
- Institut Klinicke A Experimentalni Mediciny
Prague, Czechia
Jan SperlRecruiting
- Hvidovre Hospital
Hvidovre, Denmark
Elias RashuRecruiting
- Hôpital Beaujon
Clichy, France
Kathleen MilordRecruiting - Hôpital de la Croix Rousse
Lyon, France
Teresa AntoniniRecruiting - Centre Francois Magendie
Pessac, France
Maeva ZysmanRecruiting - Hopital Pontchaillou Chu de Rennes
Rennes, France
Edouard Bardou-JacquetRecruiting - Hospital Purpan
Toulouse, France
Lauren AlricRecruiting - Hôpital Paul Brousse
Val-de-Marne, France
Audrey CoillyRecruiting
- Universitätsklinikum Der Rwth Aachen
Aachen, Germany
Pavel StrnadRecruiting - Charité - Campus Virchow-Klinikum-Ostring 1
Berlin, Germany
Frank TackeRecruiting - Hannover Medical School
Hanover, Germany
Heiner WedemeyerRecruiting - Universitätsklinikum Schleswig-Holstein - Campus Kiel
Kiel, Germany
Rainer GüntherRecruiting - Universitätsklinikum Tübingen
Tübingen, Germany
Christoph BergRecruiting
- Beaumont Hospital
Dublin, Ireland
Noel McElvaneyRecruiting
- Fondazione Irccs Cà Granda Ospedale Maggiore Policlinico
Milan, Italy
Luca ValentiRecruiting - Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone
Palermo, Italy
Vincenza CalvarusoRecruiting - Fondazione Irccs Policlinico San Matteo Di Pavia
Pavia, Italy
Angelo CorsicoRecruiting - Irccs Istituto Clinico Humanitas
Rozzano, Italy
Alessio AghemoRecruiting
- Amsterdam Umc - Vumc - de Boelelaan
Amsterdam, Netherlands
Withdrawn - Leiden University Medical Center
Leiden, Netherlands
Emily F.A. van 't WoutRecruiting
- Wip Warsaw Ibd Point Profesor Kierkus
Warsaw, Poland
Jaroslaw KierkusRecruiting - Id Clinic Arkadiusz Pisula
Śląskie, Poland
Withdrawn
- Cca Hospital Braga
Braga, Portugal
Carla RolandaRecruiting - Hospital Nélio Mendonça
Funchal, Portugal
Vitor PereiraRecruiting - Centro Hospitalar Do Porto
Porto, Portugal
Luis MaiaRecruiting
- Hospital Universitario Vall D'Hebron - Ppds
Barcelona, Spain
Monica Pons DelgadoRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 6 Mar 2023
- Primary completion
- 17 Jan 2029
- Completion
- 12 Dec 2031
- Last update posted
- 13 May 2026
- Registered enrollment
- 160
- Registry id
- NCT05677971
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.